• Thurs news: AbbVie Parkinson’s drug. Arch raises $3B biotech fund. Biogen dropping failed Sage tremor drug. AZ gets sought-after Tagrisso OK. Pfizer withdrawing sickle cell med. See more on our front page

What the heck happened to Legacy Allergan Neurosciences?

anonymous

Guest
Are we the "new" Primary care division? Time for a mass exodus. Who would want to stay with the buy and Bill/ and SP experience this position has? Everyone appears to be interviewing.
 

<